Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Vita Life Sciences Limited ( (AU:VLS) ).
Vita Life Sciences Limited announced a change in the director’s interest, with Director Peter Osborne acquiring 2,000 ordinary shares through an on-market trade, increasing his total holdings to 43,184 shares. This transaction reflects the director’s confidence in the company’s future prospects and may positively influence stakeholder perceptions.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of vitamins, supplements, and other health-related products. The company aims to enhance the well-being of its customers through innovative and quality offerings.
Average Trading Volume: 10,360
Technical Sentiment Signal: Buy
Current Market Cap: A$133.6M
Find detailed analytics on VLS stock on TipRanks’ Stock Analysis page.